These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 2547517)

  • 21. A new 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell lines in vitro.
    Jiao H; Shen W; Ohe Y; Miura K; Tamura T; Saijo N
    Cancer Immunol Immunother; 1992; 35(6):412-6. PubMed ID: 1394344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
    Plumb JA; Milroy R; Kaye SB
    Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemosensitivity testing of human lung cancer cell lines using the MTT assay.
    Carmichael J; Mitchell JB; DeGraff WG; Gamson J; Gazdar AF; Johnson BE; Glatstein E; Minna JD
    Br J Cancer; 1988 Jun; 57(6):540-7. PubMed ID: 2841961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of drug sensitivity by successive colony-forming assay].
    Azuma A; Hino M; Hirosawa A; Shimabukuro Z; Aoyama A; Ootsuka M; Matsusaka M; Niitani H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):815-20. PubMed ID: 3032106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.
    Kasahara K; Fujimura M; Bando T; Shibata K; Shirasaki H; Matsuda T
    Br J Cancer; 1996 Nov; 74(10):1553-8. PubMed ID: 8932334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity of human pancreatic adenocarcinoma tumor lines to chemotherapy, radiotherapy, and hyperthermia.
    Tsubouchi H; Takao S; Aikou T
    Hum Cell; 2000 Dec; 13(4):203-12. PubMed ID: 11329936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.
    Pieters R; Huismans DR; Leyva A; Veerman AJ
    Cancer Lett; 1988 Aug; 41(3):323-32. PubMed ID: 3165705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay.
    Lee YC; Saijo N; Sasaki Y; Takahashi H; Sakurai M; Ishihara J; Hoshi A; Chen KM; Hamburger AW
    Jpn J Clin Oncol; 1985 Dec; 15(4):637-44. PubMed ID: 4094096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay.
    Cole SP
    Cancer Chemother Pharmacol; 1986; 17(3):259-63. PubMed ID: 3742711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
    Hospers GA; Meijer C; de Leij L; Uges DR; Mulder NH; de Vries EG
    Int J Cancer; 1990 Jul; 46(1):138-44. PubMed ID: 2163989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
    Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of chemosensitivity testing with highly purified tumor cells in 435 patients with gastric carcinoma using an MTT assay.
    Noguchi K; Iwahashi M; Tani M; Nakamura M; Nakamori M; Nakatani Y; Ueda K; Ishida K; Naka T; Ojima T; Hotta T; Mizobata S; Yamaue H
    Anticancer Res; 2005; 25(2A):931-7. PubMed ID: 15868930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
    Yang JX; Luo Y; Qiu HM; Tang WX
    Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
    Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serine protease inhibition and mitochondrial dysfunction associated with cisplatin resistance in human tumor cell lines: targets for therapy.
    Dong Y; Berners-Price SJ; Thorburn DR; Antalis T; Dickinson J; Hurst T; Qiu L; Khoo SK; Parsons PG
    Biochem Pharmacol; 1997 Jun; 53(11):1673-82. PubMed ID: 9264320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
    Kiura K; Ohnoshi T; Ueoka H; Takigawa N; Tabata M; Segawa Y; Shibayama T; Kimura I
    Anticancer Drug Des; 1992 Dec; 7(6):463-70. PubMed ID: 1337430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay].
    Osawa Y; Yoshida A; Asaga T; Kawahara S; Yanoma S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):471-6. PubMed ID: 8678500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP.
    Zhan M; Liu X
    Chin Med J (Engl); 1999 Apr; 112(4):336-9. PubMed ID: 11593534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL; Hwang J; Perng RP; Whang-Peng J
    Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
    Moritaka T; Kiura K; Ueoka H; Tabata M; Segawa Y; Shibayama T; Takigawa N; Ohnoshi T; Harada M
    Anticancer Res; 1998; 18(2A):927-33. PubMed ID: 9615743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.